Our prospective, targeted, next-generation sequencing study of EGFR pathway genes in tumors obtained from Filipino young-onset colorectal cancer patients [20] confirmed extensive inter- and intratumor heterogeneity, and identified dozens of novel coding region mutations, many of which have not been reported in the literature, or remain only partially characterized. The gene discussed is EGFR; the disease is colorectal cancer.